General Session

Live Cases from MCVI

Monday, February 5
9:30 AM - 10:45 AM
Location: Great Hall 1-3

Richard Neville

Associate Director, INOVA Heart and Vascular Institute
INOVA Health system
George Washington University MFA

Richard F. Neville, MD, FACS is Director of Vascular Services for the INOVA healthcare system in northern Virginia, as well as Associate Director of the INOVA Heart and Vascular Institute, and, Vice-Chairman for Surgical Sub-specialities. Dr. Neville’s prior positions include Professor of Surgery and the Ludwig Chief of the Division of Vascular Surgery at George Washington University, and, Chief of Vascular Surgery at Georgetown University. He completed medical school at the University of Maryland and a general surgery residency at Georgetown University before moving on to a fellowship at the National Institutes of Health in endovascular device development. Dr. Neville then completed a vascular surgery fellowship under the direction of Dr. Robert Hobson. Dr. Neville is a Distinguished Fellow of the Society for Vascular Surgery, and a Fellow of the American College of Surgeons and a member of many other societies including the Southern Association for Vascular Surgery. Dr. Neville is a national and international lecturer having published of over 100 manuscripts, 200 abstracts and 150 invited lectures while remaining actively involved in research and the education of students, residents, fellows, and other physicians. He has consistently been named to the Best Doctors in America and Washingtonian Top Docs. His clinical interests include lower extremity revascularization, wound healing, amputation prevention, carotid artery treatment for stroke prevention, as well as hemodialysis access.


Send Email for Richard Neville

Barry T. Katzen

Founder & Chief Medical Executive
Miami Cardiac & Vascular Institute

Barry T. Katzen is the founder and chief medical executive of the Miami Cardiac & Vascular Institute, which has served as a national model of success in multidisciplinary cooperation. He is clinical professor of radiology and surgery, Associate Dean Clinical Affairs Baptist Health, Herbert Wertheim College of Medicine, Florida International University; as well as at University of Miami, School of Medicine and University of South Florida, Morsani College of Medicine.

Dr. Katzen graduated from the University of Miami, School of Medicine in 1970, completed his internship at Jackson Memorial Hospital, residency at the New York Hospital/Cornell Medical Center, and a fellowship in cardiovascular radiology at St. Vincent’s Hospital Medical Center and the University of Rome.

Dr. Katzen is one of the pioneers of percutaneous transluminal angioplasty, peripheral thrombolysis for less invasive treatment of vascular disease and was part of the investigative team that lead to the approval of the first intravascular stent. He performed the first renal angioplasty in the United States and is considered one of the founders of interventional radiology as a specialty of medicine. He is credited with being the first to use “live patient demonstrations” in the USA, which became the benchmark for procedural education in endovascular.

Among his awards, Dr. Katzen received the Society of Interventional Radiology's (SIR) Gold Medal; the Annual Gold Medal award from the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); and the Career Achievement Award from Trans-Catheter Therapeutics (TCT).


Send Email for Barry Katzen

Daniel Clair

Chair, Department of Surgery
Palmetto Health - University of South Carolina School of Medicine

Dr. Clair Short Bio:

Daniel G. Clair is currently the Chairman of the Department of Surgery for the Palmetto Health-USC Medical Group in Columbia, SC. He completed a general and vascular surgical training program at the Brigham and Women’s Hospital and subsequently served four years as a vascular surgeon at Andrews Air Force base in Maryland, completing his service as the chief of the vascular surgery section. He has served in roles as the chair of vascular surgery at Columbia Presbyterian Medical Center from 2002-2004 and was the chair of vascular surgery at the Cleveland Clinic from 2006 to 2016. Dan has had extensive experience in endovascular and open vascular surgical techniques for dealing with complex aortic and lower extremity occlusive disease. He has published over 100 peer-reviewed articles and holds four U.S. patents.


Send Email for Daniel Clair

William A. Gray

System Chief of Cardiovascular Services
Main Line Health


Send Email for William Gray

Jihad A. Mustapha

Advanced Cardiac & Vascular Amputation Prevention Centers
Michigan State University College of Osteopathic Medicine

Dr. Mustapha is a board-certified interventional cardiologist.  He specializes in minimally invasive, non-surgical therapy for heart and peripheral vascular disease, specifically critical limb ischemi.  Dr. Mustapha graduated from Wayne State University and St. George University School of Medicine.  He has completed Fellowships in both Cardiology and Interventional Cardiology at Louisiana State University School of Medicine.  Dr. Mustapha’s is a Fellow of the American College of Cardiology and Fellow of the Society of Cardiac Angiography and Intervention. He serves as a Clinical Associate Professor of Medicine at Michigan State University College of Osteopathic Medicine. Dr. Mustapha is currently in practice at Metro Health - University of Michigan Health in Wyoming, Michigan, where he is Director of Cardiovascular Research.  Dr. Mustapha speaks internationally on the topics of below the knee disease, critical limb ischemia, alternative access, atherectomy, vessel morphology, calcification and drug eluting technology. Dr. Mustapha is the Founder and Director of the AMPutation Prevention Symposium (AMP).  He has multiple publications, including those on critical limb ischemia and amputation prevention. 


Send Email for Jihad Mustapha

Kenneth Rosenfield

Section Head Vascular Medicine and Intervention
Massachusetts General Hospital

Dr. Rosenfield is an interventional cardiologist and vascular specialist performing complex cardiac and vascular interventions. He is Section Head for Vascular Medicine and Intervention in the Division of Cardiology at Massachusetts General Hospital. He earned a masters degree in Health Care Delivery Science from Dartmouth College. In addition to being a master clinician and interventionalist, Dr. Rosenfield has dedicated much of his career to educating fellows, residents, students, and colleagues. He is the recipient of the distinguished Laennec award for his outstanding teaching and mentorship. He is also a researcher and clinical trialist. He designed and served as national principle investigator for several landmark studies, including Aspire 2, Levant 2, Superb, ACT 1, and NIH BEST-CLI trial. He is a leader in the cardiovascular world, having been elected to the Board of Governors of American College of Cardiology, immediate past-President of the MA ACC Chapter, and immediate past-President of the Society for Cardiovascular Angiography and Interventions (SCAI). Dr. Rosenfield is a founding member of VIVA, a 501c3 organization, and sits on its board of directors. At Massachusetts General Hospital, he is the Medical director of the PERT Program, which he founded with his colleagues; he also founded the National PERT Consortium, a 501c3 organization dedicated to improving management, outcomes, and awareness of Pulmonary Embolism, and he served as its initial President; he remains a member of the PERT Consortium Executive Committee.


Send Email for Kenneth Rosenfield

Frank Arko

Chief, Vascular and Endovascular Surgery Co-Director, Center for Aortic Disease Professor, Cardiovascular Surgery
Sanger Heart & Vascular Institute

Frank Arko, MD is currently Chief, Vascular and Endovascular Surgery and Co-director, Center for Aortic Disease at Carolinas Medical Center, Sanger Heart and Vascular Institute in Charlotte, NC. He received his B.S. from Texas A&M University graduating Summa Cum Laude and his M.D. with honors in 1994 from Texas A&M University. He completed his internship and his residency at Scott & White Hospital, Texas A&M University Health Science Center in 1999. Dr. Arko completed his Clinical Vascular Fellowship in 2000 and his Endovascular Fellowship in 2001 from Stanford University Hospital, CA. He completed a Post-Doctoral Research Fellowship from Stanford University Hospital in 2001.
Dr. Arko was an Assistant Professor, Director of Endovascular Surgery at Stanford University Medical Center from July 2001 to August 2004. Following this he was the Chief, Endovascular Surgery at University of Texas Southwestern in Dallas from 2004-2011. His work has resulted in more than 150 scientific articles, abstracts, books, book chapters and numerous presentations.
Dr. Arko’s clinical expertise is in stent graft treatment of thoracic and abdominal aortic aneurysmal disease, stenting and endarterectomy in carotid arterial disease, renovascular hypertension, aortoiliac occlusive disease, mesenteric vascular and minimally invasive therapy in venous disease. His research interests include simulation-based medical planning for cardiovascular disease and aortic wall microarchitecture and cyclic strain as well as device development. He is involved with multiple clinical trials.


Send Email for Frank Arko

Michael R. Jaff

Newton-Wellesley HospitalHarvard Medical School
Harvard Medical School

Michael R. Jaff, DO, professor of medicine at Harvard Medical School, became the President of Newton-Wellesley Hospital in October 2016. Prior to that, Dr. Jaff was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital. He remains an active clinical consultant in all aspects of vascular medicine, including peripheral artery disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine.
He is the founder of VasCore, the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. VasCore has participated in trial design and independent analysis of vascular laboratory images for over 180 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries.
Dr. Jaff has published extensively in the field of Vascular Medicine with over 210 peer-reviewed publications and 9 textbooks, is the Past-President of the Society for Vascular Medicine and Biology, and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention, and is a registered physician in vascular interpretation (RPVI).
In November 2011, Dr. Jaff became an alumnus of Harvard Business School after completing the General Management Program.


Send Email for Michael Jaff

Martin B. Leon

Professor of Medicine, Director, Center for Interventional Vascular Therapy
Columbia University Medical Center
Cardiovascular Research Foundation

Martin B. Leon, MD, is a Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy (CIVT) at NewYork-Presbyterian Hospital/Columbia University Medical Center. Previously, Dr. Leon was also the Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian Hospital/Columbia University Medical Center and currently he serves on the Executive Board of the NewYork-Presbyterian/Columbia Heart Valve Center. Dr. Leon was the Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education Division. CRF is the largest independent not-for-profit cardiovascular research center in the United States.
A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national principal investigator for over 50 clinical trials that have helped shape the field including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. He has co-authored almost 2,000 peer reviewed scientific publications and abstracts, which have appeared in the most prestigious medical journals. As a practicing interventional cardiologist, Dr. Leon has performed over 10,000 procedures during his career.
He is the Founder and Director of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier scientific symposium dedicated to interventional cardiovascular medicine, which celebrated its 28th anniversary last year. He has also been the Director or Co-Director of more than 100 international educational programs in the field.


Send Email for Martin Leon

Eberhard Grube

Head, Center of Innovative Interventions in Cardiology CIIC
University Hospital Bonn

Eberhard Grube, MD, FACC, FACA, FSCAI
University Hospital Bonn, Germany

Prof. Grube is Professor of Medicine, Head, Center of Innovative Interventions in Cardiology (CIIC)University Hospital Bonn,Germany and Consulting Professor, Division of Cardiovascular Medicine, at Stanford University School of Medicine.
He received his first degree in Medicine at the Rheinische Friedrich-Wilhelm-University in Bonn. His cardiology training was completed at University of Wisconsin, Medical School and University of Bonn, Medical School.
He received his Board Certification in Internal Medicine, in Cardiology and in Angiology from the North Rhine Chamber of Medical Doctors and his post-doctoral lecturing qualification “Internal Medicine“ from the Rheinische Friedrich-Wilhelm-University in Bonn.
He is a fellow of the American College of Cardiology, the American College of Angiology and the Society for Cardiac Angiography & Interventions.

His research interest include drug eluting stents, distal protection devices, debulking devices, restenosis and in-stent restenosis.


Send Email for Eberhard Grube

Ron Waksman

Director, Cardiovascular Research and Advanced Education
MedStar Heart & Vascular Institute
Georgetown University

Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.

His current research interests include brachytherapy for restenosis prevention bioabsorbable/ biodegradable stents, HDL therapy, intracoronary imaging, valvular heart disease and catheter-based treatment of renal denervation. Dr. Waksman has authored/co-authored more than 310 published manuscripts and over 230 abstracts. He is also the author/co-author of more than 20 book chapters and the editor/co-editor of six books in the field of cardiology. He serves as the Editor-in-Chief of the journal Cardiovascular Revascularization Medicine (Including Molecular Interventions) and is on the editorial boards of numerous prominent scientific journals such as the Journal of American College of Cardiology and the American Journal of Cardiology.

He earned his medical degree from the Ben Gurion University in Israel and completed residencies in medicine, cardiology, and interventional cardiology at Hadassah University in Jerusalem, Israel. Subsequently, Dr. Waksman completed his fellowship in interventional cardiology in 1994 at Emory University Hospital in Atlanta, GA.


Send Email for Ron Waksman


Live Cases from MCVI

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Live Cases from MCVI